GRUNDL, MARC,DOLLINGER, HORST,GIOVANNINI, RICCARDO,HOENKE, CHRISTOPH,HOFFMANN, MATTHIAS,KRIEGL, JAN,MARTYRES, DOMNIC,RAST, GEORG,SEITHER, PETER
申请号：
MYPI 2011004829
公开号：
MY161903A
申请日:
2010.04.01
申请国别(地区):
MY
年份:
2017
代理人:
摘要：
OBJECT OF THE PRESENT INVENTION ARE NOVEL SUBSTITUTED COMPOUNDS OF THE FORMULA 1, WHEREIN A, R¹, R², R³ AND R⁴ ARE DEFINED AS IN THE DESCRIPTION. ANOTHER OBJECT OF THE PRESENT INVENTION IS TO PROVIDE ANTAGONISTS OF CCR3, MORE PARTICULARLY TO PROVIDE PHARMACEUTICAL COMPOSITIONS COMPRISING A PHARMACEUTICALLY ACCEPTABLE CARRIER AND A THERAPEUTICALLY EFFECTIVE AMOUNT OF AT LEAST ONE OF THE COMPOUNDS OF THE PRESENT INVENTION OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF. (NO SUITABLE FIGURE)
